Search - tctmd.com

Displaying 1 - 20 of 263

Sort: Relevancy | Date

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Daily News

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

Todd Neale

December 08, 2016

News Conference News AHA 2016

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Daily News

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

L.A. McKeown

November 10, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Think Twice: BRS First

Presenter: George D. Dangas, Fabio Felice Tarantino, Francesco Saia

November 01, 2016

Presentation TCT 2016

Choose a Drug-Eluting Stent: Heres Why

Presenter: George D. Dangas, Fabio Felice Tarantino, Carlo Cernetti

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Vladimir Ganyukov

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Italy Presents: How I Managed This Case

Presenter: Ariel Finkelstein, Ugo Limbruno, Giovanni Esposito

October 31, 2016

Presentation TCT 2016

Case Presentation: Difficult DAPT Duration Decision After PCI

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Marcelo Bettinotti

October 31, 2016

Presentation TCT 2016

How to Treat Diffuse Disease With Current PCI Devices

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Italy Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno

October 31, 2016

Presentation TCT 2016

Israel Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno, Haim Danenberg

October 31, 2016

Advertisement

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Case Conclusion: How Did We Treat Our Patient?

Think Twice: BRS First

Choose a Drug-Eluting Stent: Heres Why

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Italy Presents: How I Managed This Case

Case Presentation: Difficult DAPT Duration Decision After PCI

How to Treat Diffuse Disease With Current PCI Devices

Italy Responds: How Would I Treat?

Israel Responds: How Would I Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content